120
Participants
Start Date
September 1, 2013
Primary Completion Date
December 31, 2017
Study Completion Date
July 20, 2019
recombinant human brain natriuretic peptide (rhBNP)
Patients are first given a loading dose of recombinant human brain natriuretic peptide (rhBNP) 1.5 mcg/kg, followed by continuous infusion recombinant human brain natriuretic peptide 0.01-0.01mcg/kg/min for 72 hours.
Placebo (0.9% sodium chloride)
Patients after corrective repair of Tetralogy Of Fallot will be treat with routinely therapy, including inotropics and diuretics, combined a placebo infusion 24 hours after operation.
Cardiac intensive care unit, Department of cardiothoracic vascular surgery, Shanghai Children's Medical Center, Medical college of Shanghai Jiaotong University, Shanghai
Shanghai Jiao Tong University School of Medicine
OTHER